Rapid Response Research Brief Proposals are no longer being accepted under the current Research to Advance Racial and Indigenous Health Equity Call for Proposals. However, in light of ongoing threats to health equity research funding, we anticipate launching a new round of Rapid Response Research funding in late August (contingent on RWJF funding approval).
Rapid Response Research FAQs
Below are the frequently asked questions specific to the Rapid Response Research awards. Access the General and New Research Support frequently asked questions by clicking on the appropriate link.
Common Reasons for Turndown
What were common reasons for Brief Proposal turndowns?
The Brief Proposals we received reflected all applicants' commitment to the critical work of advancing health and wellbeing. Unfortunately, we received far more applications than we are able to support due to limited resources, we were only able to fund 4% of the applications we received. A turndown is in no way reflective of the quality or value of the proposed work.
Common reasons for turndown included:
- Applicant had not received a formal notice of award;
- There was insufficient documentation of termination at the time of submission;
- Research was ineligible for RWJF funding (e.g., pharmaceutical research, population of interest is outside of the US or its territories);
- The project did not involve research; and/or
- Research was not focused on racial or Indigenous health equity (e.g., inclusion of a racial or Indigenous study population amongst other study populations was insufficient for this particular call for proposals).